Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q4 FY25 results · Jan–Mar 2025
Max Healthcare Institute reported revenue from operations of ₹1,909.74 crore (up 34.2% from Q4 FY24) and net profit of ₹319.00 crore (up 26.8% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,909.74 | 1,422.90 | +34.2% | 1,868.31 | +2.2% |
| Other income | 46.92 | 45.25 | +3.7% | 33.30 | +40.9% |
| Total income | 1,956.66 | 1,468.15 | +33.3% | 1,901.61 | +2.9% |
| Profit before tax | 402.50 | 335.73 | +19.9% | 308.87 | +30.3% |
| Net profit for the period | 319.00 | 251.54 | +26.8% | 238.80 | +33.6% |
| EPS, basic (₹) | 3.28 | 2.59 | +26.7% | 2.46 | +33.3% |
| Net margin (%) | 16.7 | 17.7 | 12.8 |
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 658.70 | 610.11 | +8.0% | 697.40 | −5.5% |
| Other income | 98.15 | 137.77 | −28.8% | 92.01 | +6.7% |
| Total income | 756.85 | 747.88 | +1.2% | 789.41 | −4.1% |
| Profit before tax | 227.23 | 290.62 | −21.8% | 198.18 | +14.7% |
| Net profit for the period | 177.39 | 241.77 | −26.6% | 138.24 | +28.3% |
| EPS, basic (₹) | 1.82 | 2.49 | −26.9% | 1.42 | +28.2% |
| Net margin (%) | 26.9 | 39.6 | 19.8 |
Consolidated
- Filed with BSE
- 20 May 2025, 21:42 IST
- Board meeting
- 20 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 20 May 2025, 21:42 IST
- Board meeting
- 20 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE